Complete Cognitive Intervention for cSLE
NCT07302113 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2026-05-01
Summary
This project will work closely with patients to design and test a new program that supports brain health in children and youth with childhood-onset lupus (cSLE). The investigators will see how practical and helpful the program is for patients.
Conditions
Interventions
- BEHAVIORAL
-
Lupus Teen Online Problem Solving program
The Lupus Teen Online Problem Solving program is a brain health intervention developed to meet the needs of youth with childhood-onset lupus. The original Teen Online Problem Solving Program (TOPS) was developed for use with families impacted by traumatic brain injury. The Lupus Teen Online Problem Solving program is based on TOPS, with modifications to maximize relevance and accessibility. The intervention is a 10 session, evidence-based telehealth program providing training in problem-solving, emotion regulation, and communication skills in a one-to-one therapist-mediated design.
Sponsors & Collaborators
-
The Hospital for Sick Children
collaborator OTHER -
Andrea Knight
lead OTHER
Principal Investigators
-
Busi Zapparoli, PhD · The Hospital for Sick Children
-
Andrea Knight, MD, MSCE · The Hospital for Sick Children
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 13 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-01-15
- Primary Completion
- 2027-01-31
- Completion
- 2027-01-31
Countries
- Canada
Study Locations
More Related Trials
-
Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus
NCT03746197 ·Status: UNKNOWN ·Phase: NA
-
Use of Social Media to Improve Medication Adherence in Adolescents and Young Adults With Systemic Lupus
NCT03218033 ·Status: COMPLETED ·Phase: NA
-
Practice of Treat-to-target on Pediatric Systemic Lupus Erythematosus: a Two-center Retrospective Study
NCT04942314 ·Status: UNKNOWN
-
LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLE
NCT04141046 ·Status: TERMINATED ·Phase: NA
-
Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLE
NCT03537638 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus
NCT01629784 ·Status: COMPLETED ·Phase: NA
-
GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus
NCT01992666 ·Status: COMPLETED ·Phase: NA
-
Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE)
NCT05426902 ·Status: COMPLETED ·Phase: NA
-
Contemplation-Based Intervention and Health Outcomes RCT in Lupus Patients
NCT04032496 ·Status: UNKNOWN ·Phase: NA
-
Improving the Assessment of SLE Disease Activity
NCT03144063 ·Status: COMPLETED
-
The Expression Profile of New Complement Components in Childhood Lupus Nephritis
NCT05082363 ·Status: UNKNOWN
-
Neuropsycatric Disorders Among Children With Systemic Lupus Erythematosus in Sohag University Hospital
NCT06449794 ·Status: RECRUITING
-
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients
NCT01359826 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study of CM313 Injection in Subjects With Systemic Lupus Erythematosus
NCT05465707 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Pilot Study to Investigate Contemplative Intervention in Lupus Patients
NCT03103243 ·Status: COMPLETED ·Phase: NA
-
Study of Systemic Lupus Erythematosus
NCT00001372 ·Status: RECRUITING
-
Wellness & Workforce Solution for Lupus/Lupus Nephritis
NCT06217107 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
NCT06839976 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus
NCT02456168 ·Status: COMPLETED
-
Dissemination of the Lupus Interactive Navigator
NCT02950714 ·Status: COMPLETED ·Phase: NA
-
A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus
NCT01702740 ·Status: COMPLETED ·Phase: PHASE1
-
Serologically Active, Clinically Stable Systemic Lupus Erythematosus
NCT00000421 ·Status: COMPLETED ·Phase: PHASE2
-
Individual Patient Exposure and Response in Pediatric Lupus
NCT04358302 ·Status: COMPLETED ·Phase: NA
-
A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus
NCT06518668 ·Status: SUSPENDED ·Phase: PHASE1
-
Motivating Individuals With Lupus to Exercise
NCT05287581 ·Status: COMPLETED ·Phase: NA